PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cordeliers Research Centre, INSERM, IMMEDIAB Laboratory, Sorbonne Université, Université de Paris, Paris, France.\', \'Department of Diabetes, Clinical Investigation Centre (CIC-9504), Lariboisière Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.\', \'Department of Diabetology, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Université de Paris, Paris, France.\', \'Department of Diabetology, Endocrinology and Nutrition, Bichat Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.\', \'INSERM, INRA, Aix Marseille University, C2VN, Marseille, France.\', \'Endocrinology, Metabolic Diseases and Nutrition Department, Assistance Publique Hôpitaux de Marseille, Marseille, France.\', \'Centre de Ressources Biologique \'biobank Lariboisière\', BB-0033-00064, APHP, Nord, Université de Paris, Paris Diderot, Hôpital Lariboisière, Paris, France.\', \'Center for Interdisciplinary Research in Biology (CIRB), College de France - Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM), Paris Sciences et Lettres (PSL) Research University, Paris, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.15252/emmm.202013038
?:hasPublicationType
?:journal
  • EMBO molecular medicine
is ?:pmid of
?:pmid
?:pmid
  • 32816392
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.44
?:rankingScore_hIndex
  • 79
is ?:relation_isRelatedTo_publication of
?:title
  • Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID-19 in type 2 diabetes.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all